Mainz Biomed B.V. (MYNZ) Stock Statistics & Valuation Metrics

Mainz Biomed B.V. has a market cap or net worth of $6.98M. The enterprise value is $4.68B.

Mainz Biomed B.V. has 3,814,853 shares outstanding. The number of shares has decreased by -2.65% in one year.

Mainz Biomed B.V.’s return on equity (ROE) is -3.58 and return on invested capital (ROIC) is -192.86%.

The current PE Ratio of Mainz Biomed B.V. is -0.19. Mainz Biomed B.V.’s PEG ratio is -12.69.

In the last 12 months, Mainz Biomed B.V. had revenue of 893.99K and earned -21.65M in profits. Earnings per share was -22.36.

In the last 12 months, operating cash flow was -17.09M and capital expenditures -254.95K, giving a free cash flow of -17.34M billion.

Mainz Biomed B.V. pays an annual dividend of ―, resulting in a dividend yield of ―

Mainz Biomed B.V. upcoming earnings date is Sep 3, 2025, TBA Not Confirmed.

Mainz Biomed B.V. as a current ratio of 1.32, with Debt / Equity ratio of 22.90%

In the past 12 months, Mainz Biomed B.V. has paid 0.00 in taxes.

Mainz Biomed B.V. EV to EBITDA ratio is -0.06, with an EV/FCF ratio of -0.07.

Mainz Biomed B.V. has $6.24M in cash and marketable securities with $3.27M in debt, giving a net cash position of -$2.96M billion.

Gross margin is 34.38%, with operating margin of -2091.23%, and net profit margin of -2421.80%.

The average price target for Mainz Biomed B.V. is $14.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy